Puren Pharma Gmbh & Co. Kg opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Puren Pharma Gmbh & Co. Kg

Patent Number:
Title:
Dosage Form Containing Oxycodone And Naloxone
Opposition Date:
Jul 26, 2023
Patent Number:
Title:
Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound
Applicant:
Opposition Date:
May 25, 2021
Patent Number:
Title:
Rapamycin Derivative For Treating Pancreas Cancer
Applicant:
Opposition Date:
Apr 29, 2020

Competitors of Puren Pharma Gmbh & Co. Kg

AMGEN INC.

AMGEN, INC

EURO-CELTIQUE S.A.

Want to track Puren Pharma Gmbh & Co. Kg?

Feel free to send us a message here and we will get back to you